Researchers Point To MedTech Overuse Amid Reform Debate
This article was originally published in The Gray Sheet
Several academic research teams highlighted cases of overuse of medical technologies last week, just as the device industry is stepping up efforts to remove itself from the crosshairs of policymakers looking to cut spending and raise revenues as part of health care reform
You may also be interested in...
Minimally invasive removal of the prostate has some advantages, but it does not measure up to traditional open surgery in preventing incontinence and erectile dysfunction, Harvard researchers reported in the Journal of the American Medical Association Oct. 14
An amendment that would have stripped a proposed $4 billion annual fee on device manufacturers from health care reform legislation was voted down by Senate Finance Committee Democrats Oct. 1, but they signaled an interest to negotiate further
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.